Variability, Mean, and Baseline Values of Metabolic Parameters in Predicting Risk of Type 2 Diabetes

J Clin Endocrinol Metab. 2022 Apr 19;107(5):1270-1279. doi: 10.1210/clinem/dgac017.

Abstract

Context: The effect of baseline (B) and alteration of metabolic parameters (MPs), including plasma glucose (PG) testing, insulin resistance surrogates, and lipid profile and their mutual interactions on the development of type 2 diabetes mellitus (T2DM), has not been investigated systematically.

Objective: To access the association of the past variability (V), past mean (M), and B values of various MPs and their mutual interaction with the risk of T2DM.

Methods: A community-based, longitudinal analysis was conducted using the Korean Genome and Epidemiology Study comprising 3829 nondiabetic participants with completed MPs measurements during 3 biannually visits who were followed over the next 10 years. Outcomes included the incidence of T2DM during follow-up.

Results: Among predictors, PG concentrations measured during the oral glucose tolerance test were the most prominent T2DM determinants, in which the M of the average value of fasting PG (FPG), 1-hour, and 2-hour PGs had the strongest discriminative power (hazard ratios and 95% CI for an increment of SD: 3.00 (2.5-3.26), AUC: 0.82). The M values of MPs were superior to their B and V values in predicting T2DM, especially among postload PGs. Various mutual interactions between indices and among MPs were found. The most consistent interactants were the M values of high-density lipoprotein cholesterol and the M and V values of FPG. The findings were similar in normal glucose tolerance participants and were confirmed by sensitivity analyses.

Conclusion: Postload PG, past alteration of measurements, and mutual interactions among indices of MPs are important risk factors for T2DM development.

Keywords: alteration; interaction term; metabolic parameters; type 2 diabetes; variability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2* / epidemiology
  • Diabetes Mellitus, Type 2* / etiology
  • Fasting
  • Glucose Tolerance Test
  • Humans
  • Insulin Resistance*
  • Risk Factors

Substances

  • Blood Glucose